Plasminogen Activation Without Changes in tPA and PAI-1 in Response to Subcutaneous Administration of Ancrod

By Dempfle C.-E.   Alesci S.   Kucher K.   Muller-Peltzer H.   Rubsamen K.   Borggrefe M.  

Thrombosis Research, Vol. 104, Iss. 6, 2001-12 ,pp. : 433-438

Elsevier

Access to resources Recommend Favorite

AMOUNTS OF tPA AND PAI-1 IN THE EUGLOBULIN FRACTION OBTAINED AT DIFFERENT pH: THEIR RELATION TO THE EUGLOBULIN CLOT LYSIS TIME.

By Urano T.   Nishikawa T.   Nagai N.   Takada Y.   Takada A.  

Thrombosis Research, Vol. 88, Iss. 1, 1997-10 ,pp. : 75-80

Elsevier

Access to resources Recommend Favorite

Expression of PAI-1, t-PA and u-PA in cultured human umbilical vein endothelial cells derived from racial groups

By Frist S.T.   Taylor H.A.   Kirk K.A.   Grammer J.R.   Li X.-N.   Grenett H.E.   Booyse F.M.  

Thrombosis Research, Vol. 77, Iss. 3, 1995-02 ,pp. : 279-290

Elsevier

Access to resources Recommend Favorite

The Role of the t-PA I/D and PAI-1 4G/5G Polymorphisms in African-American Adults With a Diagnosis of Myocardial Infarction or Venous Thromboembolism

By Hooper W.C.   Lally C.   Austin H.   Renshaw M.   Dilley A.   Wenger N.K.   Phillips D.J.   Whitsett C.   Rawlins P.   Evatt B.L.  

Thrombosis Research, Vol. 99, Iss. 3, 2000-06 ,pp. : 223-230

Elsevier

Access to resources Recommend Favorite

Plasma Plasminogen Activator Inhibitor 1 (PAI-1) and p-Selectin Levels in Urgent Hypertension: Effect of Single Dose Captopril and Nifedipin on Fibrinolytic Activity

By Tiryaki Ozlem   Buyukhatipoglu Hakan   Usalan Celalettin  

Clinical and Experimental Hypertension, Vol. 32, Iss. 6, 2010-10 ,pp. : 347-351

Informa Healthcare

Access to resources Recommend Favorite